The effect of moderate alcohol use differs in patients who have nonalcoholic fatty liver disease and those who don't, according to a study by led by Yoosoo Chang, MD, PhD, from Sungkyunkwan University in South Korea that was published in Hepatology. Patients with NALFD who were obese and drank moderately had an increased risk of hepatic steatosis, while those without NALFD had a decreased risk, the study said.
Risk of hepatic steatosis from moderate alcohol use differs
Sign up for ACG SmartBrief
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.